Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05428969
What this trial is testing

Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndromes+1 more
Faron Pharmaceuticals Ltd 181
Post-approval studies (Phase 4)Study completedNCT00365508
What this trial is testing

Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Fox Chase Cancer Center 642
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Not applicableStudy completedNCT02551718
What this trial is testing

High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Recurrent Acute Leukemia of Ambiguous LineageRecurrent Acute Lymphoblastic LeukemiaRecurrent Acute Myeloid Leukemia+3 more
University of Washington 34
Early research (Phase 1)Study completedNCT02582359
What this trial is testing

MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital 39
Not applicableStudy completedNCT01419496
What this trial is testing

Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 40
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Not applicableUnknownNCT05791890
What this trial is testing

GilteRInf 2022 Study (Gilteritinib Related Infections)

Who this might be right for
Acute Myeloid Leukemia
University of Rome Tor Vergata 78
Not applicableUnknownNCT00172562
What this trial is testing

Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital
Large-scale testing (Phase 3)UnknownNCT01226303
What this trial is testing

Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica 300
Early research (Phase 1)Ended earlyNCT02319369
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Daiichi Sankyo 74
Early research (Phase 1)UnknownNCT05982756
What this trial is testing

Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML

Who this might be right for
BortezomibAcute Myeloid Leukemia
Zhongnan Hospital 40
Early research (Phase 1)UnknownNCT05467254
What this trial is testing

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Testing effectiveness (Phase 2)UnknownNCT04906031
What this trial is testing

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid LeukemiaMyeloid Malignancy+3 more
First Affiliated Hospital of Jinan University 5
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Early research (Phase 1)Ended earlyNCT01455025
What this trial is testing

Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
French Innovative Leukemia Organisation 11
Not applicableEnded earlyNCT00967525
What this trial is testing

Intraosseous Infusion of Unrelated Cord Blood Grafts

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+1 more
Emory University 5
Early research (Phase 1)Study completedNCT00470197
What this trial is testing

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
National Cancer Institute (NCI) 35
Not applicableUnknownNCT04460950
What this trial is testing

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Who this might be right for
Acute Myeloid LeukemiaFamilial Acute Myeloid LeukemiaMyelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto 237
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07726576
What this trial is testing

Venetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital, Bordeaux 41
Next Page